Advice
Following an abbreviated submission
brinzolamide (Azopt) eye drops are accepted for use within NHS Scotland to decrease elevated intraocular pressure in ocular hypertension and open-angle glaucoma as monotherapy in patients unresponsive to beta-blockers or in patients in whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues.
This abbreviated submission relates to a licence extension to cover use of brinzolamide with prostaglandin analogues. For patients in whom brinzolamide is an appropriate choice of therapy, this licence extension is not associated with a price increase and is not expected to increase drug usage.
Download detailed advice44KB (PDF)
Medicine details
- Medicine name:
- brinzolomide 10mg/ml eye drops, suspension (Azopt)
- SMC ID:
- 546/09
- Indication:
- Elevated intraocular pressure in ocular hypertension & open-angle glaucoma. Monotherapy in patients unresponsive to beta-blockers or where beta-blockers are contraindicated. Adjunctive therapy to beta
- Pharmaceutical company
- Alcon Laboratories UK Ltd
- BNF chapter
- Eye
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 14 April 2009